Taken together, our studies showed that reciprocal interaction between Cobll1, PACSIN2, and SH3BP1 is closely linked to drug resistance and BC progression in CML. The gene discussed is PACSIN2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.